saracatinib
E2103744
UNEXPLORED
Saracatinib is an experimental small-molecule tyrosine kinase inhibitor being investigated primarily for its potential in treating various cancers and other diseases driven by aberrant Src family kinase signaling.
All labels observed (1)
| Label | Occurrences |
|---|---|
| saracatinib canonical | 1 |
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.